SCHEMBL6153418

SCHEMBL6153418

O=C(O)COC(c1c[c]ccc1)c1cccc(C(F)(F)F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.44
IDO1 P14902 1/20 0.44
TDO2 P48775 1/20 0.44
ACP3 P15309 2/20 0.40
CES2 O00748 1/20 0.40
PNMT P11086 1/20 0.40
SLC6A9 P48067 2/20 0.39
CHRM2 P08172 1/20 0.38
CHRM4 P08173 1/20 0.38
CHRM3 P20309 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.38
EPHX1 P07099 2/20 0.37
FFAR4 Q5NUL3 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
POLB P06746 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9293034 0.86 IDO1 (0.58) GAAIDO1TDO2ACP3CES2
SCHEMBL6154991 0.85 GAA (0.43) GAAIDO1TDO2CES2PNMT
Ammonia Solution, Strong SCHEMBL10334616 0.85 IDO1 (0.57) GAAIDO1TDO2ACP3CES2
Propane SCHEMBL10335007 0.83 IDO1 (0.52) GAAIDO1TDO2ACP3CES2
SCHEMBL6154126 0.83 IDO1 (0.45) GAAIDO1TDO2ACP3CES2
Isopropylamine SCHEMBL10335006 0.82 IDO1 (0.54) GAAIDO1TDO2ACP3PNMT
SCHEMBL6154730 0.80 CACNA2D1 (0.45) ACP3CES2PNMTSLC6A9EPHX1
SCHEMBL10334580 0.76 IDO1 (0.59) GAAIDO1TDO2ACP3CES2
Butylamine SCHEMBL10335002 0.76 IDO1 (0.50) GAAIDO1TDO2ACP3PNMT
SCHEMBL6156534 0.74 EPHX1 (0.41) ACP3CES2PNMTSLC6A9CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP GAA 2365/4885IDO1 1533/4885TDO2 1494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.